These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8079289)

  • 1. [Frequency of check-ups during post-climacteric hormonal treatment].
    Nordby K
    Tidsskr Nor Laegeforen; 1994 Jun; 114(15):1738-9. PubMed ID: 8079289
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 4. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].
    Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].
    Hovelius B
    Lakartidningen; 2002 Jul; 99(28-29):3014-5. PubMed ID: 12170508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Menopause hormonal treatment and risk of breast cancer: comments on the results of the Million Women Study].
    Fournier A; Clavel-Chapelon F; Hill C
    Bull Cancer; 2003 Oct; 90(10):924-6. PubMed ID: 14706923
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estrogen therapy in climacteric. Current views in an evidence-based perspective].
    Nilsson K
    Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():409-10. PubMed ID: 12448047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone therapy in climacteric. Varying research results on risks and benefits].
    Magnusson C; Persson I
    Lakartidningen; 1997 Mar; 94(13):1176-9. PubMed ID: 9148053
    [No Abstract]   [Full Text] [Related]  

  • 10. [The climacteric and its hormonal treatment].
    Gvorgiev DB
    Akush Ginekol (Sofiia); 1993; 32(1):36-40. PubMed ID: 8172347
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombophilic profile of climacteric and menopausal women with venous thromboembolism.
    Margarido PF; D'Amico E; Bagnoli VR; Fonseca AM; Halbe HW; Pinotti JA
    Climacteric; 2002 Mar; 5(1):87-9. PubMed ID: 11974563
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone replacement in patients at high risk for thromboses].
    Hiller F
    Internist (Berl); 1997 Oct; 38(10):999-1000. PubMed ID: 9432514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Estrogen during and after climacteric--problems and possibilities for primary health care].
    Blivik J
    Lakartidningen; 2001 Mar; 98(10):1145-6. PubMed ID: 11301984
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is estrogen replacement therapy increasing or decreasing the risk of cancer?].
    Auranen A; Grénman S; Anttila L; Salmi T
    Duodecim; 2003; 119(22):2199-206. PubMed ID: 14702809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormonal replacement therapy and breast cancer].
    Noël G; Feuvret L; Gasowski M; Bernard A; Cappelaere P
    Bull Cancer; 1998 Dec; 85(12):997-1014. PubMed ID: 9917553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of vaginal smears in the follow-up od menopausal symptoms].
    Szántó F
    Orv Hetil; 1998 Mar; 139(12):693-5. PubMed ID: 9555166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risks and benefits of postmenopausal hormone replacement therapy].
    Szántó F
    Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does menopausal hormonal replacement therapy increase the risk of breast cancer?].
    Punnonen R
    Duodecim; 1996; 112(12):1110-5. PubMed ID: 10593013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current status: hormone substitution and risk of endometrial carcinoma].
    Kuhl H
    Zentralbl Gynakol; 1997; 119(6):296-7. PubMed ID: 9312968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.